Hillstream BioPharma, Inc.
HILS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7,610 | $2,242 | $1,076 | $3,559 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $89 | $288 | $585 | $162 |
| Total Curr. Assets | $7,699 | $2,530 | $1,661 | $3,722 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,699 | $2,530 | $1,661 | $3,722 |
| Liabilities | – | – | – | – |
| Payables | $659 | $771 | $838 | $1,090 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $885 | $1,392 | $1,638 | $1,324 |
| Total Curr. Liab. | $1,545 | $2,163 | $2,476 | $2,414 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,545 | $2,163 | $2,476 | $2,414 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $0 | $0 | $0 |
| Retained Earnings | -$43,400 | -$41,298 | -$39,443 | -$36,901 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $49,554 | $41,665 | $38,628 | $38,209 |
| Total Equity | $6,155 | $367 | -$815 | $1,308 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,699 | $2,530 | $1,661 | $3,722 |
| Net Debt | -$7,610 | -$2,242 | -$1,076 | -$3,559 |